WO2014021073A1 - Cornée artificielle et procédé de production de cornée artificielle - Google Patents

Cornée artificielle et procédé de production de cornée artificielle Download PDF

Info

Publication number
WO2014021073A1
WO2014021073A1 PCT/JP2013/068987 JP2013068987W WO2014021073A1 WO 2014021073 A1 WO2014021073 A1 WO 2014021073A1 JP 2013068987 W JP2013068987 W JP 2013068987W WO 2014021073 A1 WO2014021073 A1 WO 2014021073A1
Authority
WO
WIPO (PCT)
Prior art keywords
cornea
artificial cornea
forming
artificial
forming substrate
Prior art date
Application number
PCT/JP2013/068987
Other languages
English (en)
Japanese (ja)
Inventor
中山泰秀
上地正実
滝山直昭
Original Assignee
独立行政法人国立循環器病研究センター
学校法人日本大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 独立行政法人国立循環器病研究センター, 学校法人日本大学 filed Critical 独立行政法人国立循環器病研究センター
Publication of WO2014021073A1 publication Critical patent/WO2014021073A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Definitions

  • the present invention relates to an artificial cornea formed in an environment in which a living tissue material exists such as in a living body, and a method for producing an artificial cornea.
  • one of the important causes of visual impairment is a disease that causes turbidity of the cornea.
  • these corneal diseases infection and trauma such as viruses and bacteria, hereditary corneal diseases, etc. are treated with the cornea. Requires transplantation.
  • donor corneas registered and donated to the eye bank are used for corneal transplantation, but in Japan in recent years, the number of eyes donated is about 1000 per year, while the number of cornea transplants is about 1500 per year, The number of patients is said to be 2000 to 3000, and donor corneas imported from overseas are used for some corneal transplants. Furthermore, even if imported donor corneas are used, the countries where eye banks are established are limited to developed countries, and the eye banks are not established in the developing countries, and the cornea becomes incompatible with transplantation due to infection. There is a problem that it is often.
  • amniotic membrane may be transplanted instead of donor cornea, and corneal opacity is caused by infection, trauma, or inherited corneal disease.
  • Endothelial cell damage is a limited disease, and good results have been obtained in the treatment of corneal parenchymal disorders centering on collagen fibers.
  • research on cultured corneas and other artificial corneas applying regenerative medical technology has been conducted, and these artificial corneas are particularly useful for corneal epithelial stem cells and corneal endothelial cells in which cell proliferation ability is important. Expected to be effective in treating diseases.
  • amniotic transplantation is a cross-transplantation, although it has the advantage of requiring secondary corneal transplantation due to limited transparency recovery of the amniotic transplantation part and being less likely to cause rejection. Therefore, the risk of infection cannot be excluded.
  • the cultured cornea it requires cell culture equipment and engineers having knowledge and techniques thereof, and, regarding other artificial corneas, those made of various materials have been studied, At present, no artificial cornea has been developed that is easy to produce and provides good long-term results.
  • an artificial cornea by, for example, forming an artificial cornea made of connective tissue in a living body, and further, by forming the artificial cornea in the body of itself, The risk of subsequent infections and rejection can be expected to be extremely low.
  • a base material is embedded in the living body, a connective tissue is formed around it, and this is used as an artificial cornea.
  • a technique similar to that for forming can be used.
  • This method uses living body's self-defense reaction to form living tissue such as artificial blood vessels and artificial valves from living cells. A plurality of forming techniques have been reported (see Patent Documents 1 to 3).
  • the self-defense reaction used in this method is a connective tissue mainly composed of fibroblasts and collagen when fibroblasts gradually gather around them when foreign objects such as thorns invade deep in the body. It is a reaction that attempts to isolate a foreign body in the body by forming a capsule of the body and covering the foreign body.
  • an artificial cornea having a desired shape and size can be formed by appropriately setting the shape and size of a base material as a foreign substance to be embedded in a living body. .
  • an artificial cornea is formed around a base material implanted in a living body, it is possible to appropriately set the shape and size of the base material and form an artificial cornea of a desired shape and size around the base. Although it is possible, the artificial cornea cannot be formed to a desired thickness.
  • the surface condition such as the smoothness of the substrate, the surface of the artificial cornea on the substrate side can be formed in a desired surface state, but the surface opposite to the substrate is desired. The surface state cannot be formed.
  • An object of the present invention is to provide an artificial cornea capable of forming an artificial cornea having a desired thickness and capable of forming both surfaces of the artificial cornea into a desired surface state and a method for producing the artificial cornea.
  • an artificial cornea according to the present invention is formed on the surface of a base material in an environment where a biological tissue material exists, and both surfaces of the artificial cornea are formed according to the surface of the base material. Is.
  • both surfaces of the artificial cornea are formed to match the surface of the substrate, both surfaces of the artificial cornea are formed, such as forming the substrate surface on a smooth surface and forming both surfaces of the artificial cornea on a smooth surface. It can be set to a desired surface state, and the artificial cornea can be set to a desired thickness by appropriately setting the distance between the surfaces of the base material forming both surfaces of the artificial cornea. Furthermore, by forming both sides of the artificial cornea on the surface of the base material, it is possible to reach the part of the artificial cornea that is farthest from the base material surface, compared to the case where an artificial cornea is formed by matching one side with the base material surface. The distance can be shortened, the artificial cornea can be thickened and the density can be made uniform.
  • the “biological tissue material” is a substance necessary for forming a desired biological tissue, such as fibroblasts, smooth muscle cells, endothelial cells, stem cells, ES cells, iPS cells, etc.
  • the “biological tissue material” includes materials derived from mammals such as humans, dogs, cows, pigs, goats and sheep, birds, fish and other animals, or artificial materials equivalent thereto.
  • “in the environment where biological tissue material is present” means in vivo (for example, limbs, mammals such as humans, dogs, cows, pigs, goats, sheep, birds, fish, and other animals). It refers to an artificial environment containing a biological tissue material outside the living body of an animal), or subcutaneously in the waist, back or abdomen, or embedded in the abdominal cavity.
  • the artificial cornea may be formed in a spherical shape with the central portion swelled, and an excess portion around the artificial cornea may be removed.
  • the base material is provided with a pair of spherical portions that form both surfaces of the artificial cornea so that the artificial cornea matches the spherical shape of the eyeball to be transplanted.
  • a portion for holding a pair of spherical portions at a predetermined interval can be provided around the spherical portion, and the structure of the base material for forming the spherical artificial cornea can be simplified. .
  • the present invention is a base material that can be placed in an environment where a biological tissue material exists to form an artificial cornea on the surface of the base material, and the artificial cornea is formed so that both surfaces of the artificial cornea are formed on the base material surface.
  • An artificial cornea-forming substrate is provided in which two cornea-forming surfaces that form a surface are provided to face each other.
  • an artificial cornea having a desired thickness can be formed by appropriately setting the interval therebetween.
  • both sides of the artificial cornea are formed according to the substrate surface, both sides of the artificial cornea are formed in a desired surface state, such as forming the cornea-forming surface into a smooth surface and forming both surfaces of the artificial cornea into a smooth surface. can do.
  • an artificial cornea is formed between two opposing cornea-forming surfaces, a portion of the artificial cornea that is farthest from the cornea-forming surface than when an artificial cornea is formed outside the one cornea-forming surface. Can be shortened, and a thick and uniform artificial cornea can be formed. That is, it is possible to form an artificial cornea similar to the above-mentioned artificial cornea having a desired sufficient thickness, a uniform density, and both surfaces having a desired surface state.
  • the artificial cornea-forming substrate of the present invention is not particularly limited in terms of the shape of the cornea-forming surface, the entire structure of the substrate, etc. as long as the two cornea-forming surfaces are provided facing each other. Various types can be adopted depending on the shape of the artificial cornea to be formed.
  • the artificial cornea-forming base material a plurality of plate-like base materials having a cornea-forming surface are provided at intervals, and the plurality of plate-like base materials can be separated from each other.
  • an artificial cornea can be formed in the gap between the plate-like base materials, and a plurality of sheets By disassembling the plate-like substrate, the artificial cornea formed between the plate-like substrates can be easily taken out.
  • a pair of base materials having a cornea-forming surface is provided, and the cornea-forming surfaces of the pair of base materials are divided into a spherical convex surface and a central portion with a central portion swelled It is also possible to use a hollow spherical concave surface that is formed at a distance from each other so that the pair of base materials can be disassembled from each other.
  • the spherical convex surface and the concave surface are provided as a cornea-forming surface and spaced apart from each other, a spherical artificial cornea can be formed in the gap between the cornea-forming surfaces.
  • the artificial cornea formed between the cornea-forming surfaces can be easily taken out by decomposing the base material.
  • the distance between the two corneal forming surfaces is not particularly limited, but it is preferable to set the interval between the corneal forming surfaces to 0.1 mm to 2 mm.
  • an artificial cornea having a sufficient thickness as a cornea can be formed, and the gap between the two cornea-forming surfaces is set at a sufficient interval for the connective tissue to enter.
  • the artificial cornea having a uniform density can be formed by sufficiently reducing the distance from an arbitrary position to the corneal surface.
  • the surface roughness of the cornea-forming surface is not particularly limited, but it is preferable to set the surface roughness of the cornea-forming surface to an arithmetic average roughness of 50 ⁇ m or less.
  • the connective tissue is easily invaded to improve the connective tissue formation state, and both sides of the artificial cornea are set to be sufficiently smooth as the cornea.
  • the artificial cornea can be easily peeled off from the cornea-forming surface.
  • the present invention also provides a method for producing an artificial cornea using the artificial cornea-forming substrate. That is, in the method for producing an artificial cornea according to the present invention, an artificial cornea-forming substrate is placed in an environment where biological tissue material is present, and a connective tissue is formed around the artificial cornea-forming substrate, A forming step of forming a connective tissue between the corneal forming surfaces facing each other, a step of taking out the artificial corneal forming substrate coated with the connective tissue from the environment, and a corneal forming surface from the artificial corneal forming substrate. And a separation step of peeling the connective tissue between them to take out as an artificial cornea. Furthermore, in the separation step, after the connective tissue around the artificial cornea-forming substrate is removed, the artificial cornea-forming substrate is disassembled and the artificial cornea is taken out.
  • any of autotransplantation, allotransplantation, and xenotransplantation may be used for the transplant recipient, but autotransplantation or allotransplantation is preferable from the viewpoint of avoiding rejection.
  • a biological tissue material that promotes the formation of connective tissue may be accommodated between the corneal formation surfaces facing each other.
  • the biological tissue material that promotes the formation of connective tissue is, for example, blood, fat, collagen, gelatin, and those containing a growth factor or the like.
  • the connective tissue grows and gradually enters the space between the corneal formation surfaces.
  • the time required for the tissue formation can be shortened and the tissue formation can be made more reliable than waiting for the above.
  • the artificial cornea-forming base material is provided with an LED that can promote the formation of connective tissue, and a drug container that stores and gradually releases a drug that can promote the formation of connective tissue.
  • the two cornea-forming surfaces are opposed to each other, and the artificial cornea is formed by aligning both surfaces thereof with the surface of the substrate. Therefore, by appropriately setting the interval between the cornea-forming surfaces, It is possible to obtain an artificial cornea having a desired surface state such as a thickness, a smooth surface on both sides, a sufficient thickness, and a uniform density.
  • Photograph showing an artificial cornea according to the present invention Photograph showing cut surface of artificial cornea
  • Perspective view of base material for artificial cornea formation Photo showing connective tissue formed on the substrate surface It is the photograph which shows the artificial cornea transplanted to the eyeball, (a) 1 day after transplant, (b) 5 days after transplant, (c) 15 days after transplant.
  • a perspective view of an artificial cornea-forming substrate having a spherical cornea-forming surface A photograph showing the connective tissue formed on the surface of the artificial cornea-forming substrate of FIG.
  • the artificial cornea 1 shown in FIGS. 1 and 2 is obtained by separating the connective tissue formed on the surface of the artificial cornea-forming substrate 2 from the surface of the substrate in an environment where a biological tissue material exists, and has a desired shape. It is cut and used for corneal transplantation.
  • the artificial cornea 1 is formed in a state where both surfaces thereof are in contact with the base material surface, is formed to have a desired thickness, a sufficient thickness, and a uniform density, and further, both surfaces are formed smoothly. .
  • the artificial cornea-forming substrate 2 is for placing the artificial cornea 1 on the surface of the substrate by placing it in an environment in which a biological tissue material exists.
  • 3a and 3b are provided at a distance from each other, and the two opposing surfaces of the two plate-like base materials 3a and 3b form the artificial cornea 1 so that both surfaces of the artificial cornea 1 are formed on the base material surface.
  • the cornea forming surface 4 is formed.
  • the plate-like base materials 3a and 3b are rectangular plates having the same shape, which are slightly curved, and are arranged in a positional relationship in which they are moved parallel to each other in the thickness direction of the central portion, and can be separated from each other via the connecting portions 5 at the four corners. Is integrated.
  • the coupling portion 5 is formed in a cylindrical shape with a small diameter, and by appropriately setting the length thereof, the pure interval between the plate-like substrates 3a and 3b, which is the interval between the cornea forming surfaces 4, is set. By cutting the plate-like base materials 3a and 3b.
  • the shape, size, and pure interval of the plate-like base materials 3a, 3b are set according to the shape, size, and thickness of the artificial cornea 1 to be formed.
  • the interval between the two cornea-forming surfaces 4 Is set to 0.1 mm to 2 mm.
  • the surface state of the cornea-forming surface 4 is set according to the surface state such as smoothness to be formed of the artificial cornea 1.
  • the surface roughness of the cornea-forming surface 4 is an arithmetic average roughness of 50 ⁇ m or less. Is set.
  • the number of plate-like substrates is not limited to two, and may be three or more. May be formed.
  • the material composing the artificial cornea-forming substrate 2 is not particularly limited, but strength (hardness), chemical stability, and sterilization that can prevent deformation due to implantation in a living body. Resins that have resistance to load and satisfy the condition that there is little or no eluate that stimulates the living body are preferable, and silicone resins and acrylic resins can be exemplified.
  • This production method includes an “installation step” in which the artificial cornea-forming substrate 2 is placed in an environment where biological tissue material exists, and a cornea that faces each other while forming a connective tissue around the artificial cornea-forming substrate 2.
  • “Formation step” of forming connective tissue between the formation surfaces 4 “Extraction step” of taking out the artificial cornea-forming substrate 2 covered with connective tissue from the environment, and cornea from the artificial cornea-forming substrate 2 It consists of a “separation step” in which the connective tissue between the formation surfaces 4 is peeled off and taken out as an artificial cornea 1.
  • the environment in which the biological tissue material exists includes in an animal's living body (for example, subcutaneously or intraperitoneally embedded) or in an artificial environment such as a solution in which the biological tissue material floats outside the animal's body.
  • biological tissue materials materials derived from other mammals such as humans, dogs, cows, pigs, goats, rabbits, sheep, birds, fish, other animals, or artificial materials can also be used.
  • the artificial cornea-forming substrate 2 When embedding the artificial cornea-forming substrate 2 in an animal, it is performed with a minimum of incision under sufficient anesthesia, and the wound is sutured after implantation.
  • part of the base material 2 for artificial cornea formation the intraperitoneal cavity which has the volume which receives the base material 2 for artificial cornea formation, or subcutaneous, such as an extremity part, a shoulder part or a back part, an abdomen, is preferable.
  • cell culture may be performed according to a known method in a clean environment with various culture conditions.
  • a film-like connective tissue is formed around the artificial cornea-forming substrate 2, and the connective tissue grows to form a cornea of the plate-like substrates 3a and 3b. It is formed so as to penetrate between the surfaces 4.
  • the connective tissue is composed of an extracellular matrix such as fibroblasts and collagen, and is formed to a thickness corresponding to the pure interval between the plate-like substrates 3a and 3b.
  • stimulates formation of a connective tissue is accommodated between the cornea formation surfaces 4 at the installation process, it gradually enters into the space between the cornea formation surfaces 4 while the connective tissue grows. The time required for the tissue formation is shortened and the tissue formation is more reliably performed than waiting for the going.
  • ⁇ Removal process> After the connective tissue is sufficiently formed through the formation process for a predetermined time, an extraction process of taking out the artificial cornea-forming substrate 2 from the environment where the biological tissue material exists is performed.
  • the artificial cornea-forming substrate 2 taken out from the environment in which the biological tissue material exists is entirely covered with a membrane made of connective tissue (see FIG. 4).
  • ⁇ Separation process> The connective tissue around the artificial cornea-forming substrate 2 is removed, the joint portions 5 at the four corners are cut, and the artificial cornea-forming substrate 2 is disassembled into two plate-like substrates 3a and 3b. Remove 1 and remove.
  • This artificial cornea 1 has a high quality and uniform density in the shape, size, thickness and surface state corresponding to the curved surface shape, size, pure interval and smoothness of the cornea-forming surface 4 of the plate-like substrates 3a, 3b. (See FIGS. 1 and 2).
  • the produced artificial cornea 1 is xenotransplanted, it is preferable to perform immunogen removal treatment such as decellularization treatment, dehydration treatment, and fixation treatment in order to prevent rejection after transplantation.
  • decellularization include ultrasonic treatment, surfactant treatment, and enzyme treatment such as collagenase to elute and wash the extracellular matrix.
  • Dehydration methods include methanol, ethanol, isopropyl alcohol, etc. There is a method of washing with a water-soluble organic solvent, and as a method of fixing, there is a method of treating with an aldehyde compound such as glutaraldehyde or formaldehyde.
  • the artificial cornea-forming substrate 2 shown in FIG. 3 is implanted subcutaneously in the back of a 10 kg beagle dog, and the beagle dog is bred for 1 month under normal breeding conditions, and then covered with a connective tissue.
  • the forming substrate 2 was extracted (see FIG. 4).
  • the artificial cornea-forming substrate 2 is made of sterilized acrylic, and the pure interval between the plate-like substrates 3a and 3b is 0.5 mm.
  • the connective tissue formed under the skin is mainly composed of fibroblasts and collagen, encapsulates and covers the periphery of the artificial cornea-forming substrate 2, and penetrates between the cornea-forming surfaces 4 to form the artificial cornea 1.
  • the artificial cornea-forming substrate 2 covered with the connective tissue film could be easily removed from the subcutaneous tissue.
  • the connective tissue around the artificial cornea-forming substrate 2 was peeled off to separate the plate-like substrates 3a and 3b, and the internal artificial cornea 1 was taken out (see FIG. 1).
  • the cornea-forming surfaces 4 of the plate-like substrates 3a and 3b and the artificial cornea 1 were not adhered at all, and they could be easily separated without damage.
  • the thickness of the artificial cornea 1 was 0.47 ⁇ 0.2 mm, which was the same thickness as the pure interval (0.5 mm) between the plate-like substrates 3a and 3b (see FIG. 2).
  • both surfaces of the artificial cornea 1 were in the same smooth state as the cornea-forming surface 4 and had a substantially uniform density over all parts in the thickness direction (see FIG. 2).
  • the artificial cornea 1 having a desired shape, size, thickness, and surface state can be obtained.
  • the density of the artificial cornea 1 can be made substantially uniform over the entire range in the thickness direction.
  • a beagle dog male, 8 years old weighing 10 kg was given general anesthesia, and Baron's vacuum cornea trepan (diameter 6 mm) was used to make the beagle dog cornea up to a depth of 0.375 mm. An incision was made, and then the cornea was delaminated using a spatula, whereby a corneal surface resection with a diameter of 6 mm and a depth of 0.375 mm was performed to form a defect in the eyeball.
  • an artificial cornea 1 (transplanted biosheet) cut into a circle of 6.5 mm in diameter using a Baron donor corneal punch (6.5 mm in diameter) was transferred to a 10-0 nylon in the defect portion after resection of the corneal surface of a beagle dog. Suture was performed using a thread (see FIG. 5A).
  • antibiotics were instilled and administered for the prevention of infection and NSAIDs were administered systemically for analgesia, but no anti-inflammatory drugs or immunosuppressants were used.
  • the artificial cornea-forming substrate 2 has a structure in which the connecting portions 5 are provided at the four corners of the plate-like substrates 3a and 3b and the openings into which the connective tissue enters are provided on the four sides.
  • the present invention is not limited to all having openings, but may be any having openings on at least one of the four sides.
  • an artificial cornea-forming substrate 6 that forms a spherical artificial cornea may be adopted. it can.
  • the artificial cornea-forming substrate 6 is formed on a pair of substrates 7a and 7b as a cornea-forming surface, a spherical convex surface 8 having a bulged central portion and a spherical concave surface 9 having a concave central portion. It is provided at intervals.
  • a spherical convex surface 8 having a bulged central portion
  • a spherical concave surface 9 having a concave central portion. It is provided at intervals.
  • flat peripheral portions 10a and 10b are provided, and the peripheral portions 10a and 10b are connected via a plurality of connecting portions 11, so that the pair of base materials 7a and 7b are mutually connected. It is integrated so that it can be disassembled.
  • This artificial cornea-forming substrate 6 is placed in the living body of an animal and the like to form a connective tissue on the surface of the substrate, like the artificial cornea-forming substrate 2 (see FIG. 7).
  • a connective tissue on the surface of the substrate, like the artificial cornea-forming substrate 2 (see FIG. 7).
  • the artificial cornea between the convex surface 8 and the concave surface 9 can be peeled off and taken out.
  • a spherical artificial cornea having a swelled central portion so as to match the eyeball shape can be obtained.
  • connective tissue it is necessary to form a connective tissue by providing an LED capable of promoting the formation of connective tissue, or forming a drug containing portion that contains a drug capable of promoting the formation of connective tissue and gradually releases it. While shortening time, you may make it obtain the connective structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

La présente invention concerne : une cornée artificielle pouvant prendre la forme d'une épaisseur souhaitée et présenter un état de surface souhaité sur chacune de ses deux surfaces; et un procédé de production de cornée artificielle. Plus particulièrement, deux surfaces (4) de formation de cornée permettant de former une cornée artificielle (1) sont agencées de sorte à se trouver en regard l'une de l'autre. Une base (2) de formation de cornée artificielle ainsi produite est disposée dans un environnement dans lequel est présent un matériau de tissus biologiques. La cornée artificielle (1) est formée entre les surfaces (4) de formation de cornée. La cornée artificielle (1) est formée de sorte que les deux surfaces de la cornée artificielle (1) s'ajustent aux surfaces (4) de formation de cornée respectivement. La distance entre les surfaces (4) de formation de cornée est établie de manière appropriée. De cette manière, la cornée artificielle (1) présentant une épaisseur souhaitée est formée. Chacune des surfaces (4) de formation de cornée est formée de sorte à présenter une surface lisse. Chacune des deux surfaces de la cornée artificielle (1) revêt la forme d'un état de surface souhaité, tel qu'un état de surface lisse.
PCT/JP2013/068987 2012-08-03 2013-07-11 Cornée artificielle et procédé de production de cornée artificielle WO2014021073A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012-172918 2012-08-03
JP2012172918A JP2014030596A (ja) 2012-08-03 2012-08-03 人工角膜及び人工角膜の生産方法

Publications (1)

Publication Number Publication Date
WO2014021073A1 true WO2014021073A1 (fr) 2014-02-06

Family

ID=50027757

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/068987 WO2014021073A1 (fr) 2012-08-03 2013-07-11 Cornée artificielle et procédé de production de cornée artificielle

Country Status (2)

Country Link
JP (1) JP2014030596A (fr)
WO (1) WO2014021073A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3975931A4 (fr) 2019-06-03 2023-06-28 Advanced Solutions Life Sciences, LLC Système et procédé de fabrication d'une cornée

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002078723A (ja) * 2000-09-08 2002-03-19 Hoya Healthcare Corp 角膜の再構築方法
JP2002320666A (ja) * 2000-09-26 2002-11-05 Sanyo Chem Ind Ltd 人工角膜の製造方法
JP2006238987A (ja) * 2005-03-01 2006-09-14 National Cardiovascular Center 結合組織シート（バイオシート）の形成基材およびバイオシートの製造方法
JP2007312821A (ja) * 2006-05-23 2007-12-06 National Cardiovascular Center 結合組織体形成基材およびそれを用いた結合組織体の製造方法
JP2008237896A (ja) * 2007-02-26 2008-10-09 National Cardiovascular Center 結合組織体形成基材およびそれを用いた結合組織体の製造方法
JP2010094476A (ja) * 2008-10-15 2010-04-30 Shinkan Kogyo Kk 結合組織体形成用基材およびそれを用いた結合組織体の製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002078723A (ja) * 2000-09-08 2002-03-19 Hoya Healthcare Corp 角膜の再構築方法
JP2002320666A (ja) * 2000-09-26 2002-11-05 Sanyo Chem Ind Ltd 人工角膜の製造方法
JP2006238987A (ja) * 2005-03-01 2006-09-14 National Cardiovascular Center 結合組織シート（バイオシート）の形成基材およびバイオシートの製造方法
JP2007312821A (ja) * 2006-05-23 2007-12-06 National Cardiovascular Center 結合組織体形成基材およびそれを用いた結合組織体の製造方法
JP2008237896A (ja) * 2007-02-26 2008-10-09 National Cardiovascular Center 結合組織体形成基材およびそれを用いた結合組織体の製造方法
JP2010094476A (ja) * 2008-10-15 2010-04-30 Shinkan Kogyo Kk 結合組織体形成用基材およびそれを用いた結合組織体の製造方法

Also Published As

Publication number Publication date
JP2014030596A (ja) 2014-02-20

Similar Documents

Publication Publication Date Title
CN1243573C (zh) 预制的角膜组织镜片及其制备方法(ii)
JP6010018B2 (ja) 弁付きステント、弁付きステント形成用基材、及び弁付きステントの生産方法
JP6827522B2 (ja) 複合細胞外マトリックス成分生体材料
Ohki et al. Application of regenerative medical technology using tissue‐engineered cell sheets for endoscopic submucosal dissection of esophageal neoplasms
US20110045566A1 (en) method for preparing the decellularized matrix
JP5255846B2 (ja) 生体内で細胞増殖可能な角膜内皮製剤
JP2001161353A (ja) 移植用細胞片及びその作成方法
JP7282232B2 (ja) 接着状態の細胞培養物の改変方法
JP2014030598A (ja) 膜状結合組織体形成用基材及びこれを用いた膜状結合組織体の生産方法
WO2014021073A1 (fr) Cornée artificielle et procédé de production de cornée artificielle
JP6262470B2 (ja) 結合組織体形成用基材、及び結合組織体の生産方法
CN111686309A (zh) 一种3d打印皮肤的制备方法
KR101908030B1 (ko) 상처 또는 궤양치료를 위한 3차원 세포시트 및 이의 제조방법
US20170189166A1 (en) Corneal implants and methods of manufacturing
JP2009225675A (ja) 上皮系細胞シートの作製のための同種皮膚由来フィーダー細胞
WO2014010323A1 (fr) Substrat pour la formation de tissu conjonctif de type membrane et procédé de production de tissu conjonctif de type membrane l'utilisant
WO2004045666A1 (fr) Méthode de régénération d'un organe
CN109125924A (zh) 一种生物套在电子器械心脏植入方面的应用
JP5658008B2 (ja) 弁付き人工血管形成用基材、これを用いた弁付き人工血管の生産方法及び弁付き人工血管
Mutsaers et al. Future directions in mesothelial transplantation research
Baksh et al. Cell sheet engineering for integrating functional tissue in vivo: Successes and challenges
JP7262443B2 (ja) 貫通構造を有するシート状細胞培養物
JP2016136984A (ja) 管状組織体形成基材
JP2016067711A (ja) 移植用皮膚組織片の作製方法
JP2006238987A (ja) 結合組織シート（バイオシート）の形成基材およびバイオシートの製造方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13826446

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13826446

Country of ref document: EP

Kind code of ref document: A1